Newsletter March 2017 No.178
Top News
Held "Regular Chairman's Press Conference
On January 17, 2017, the JPMA held its "Regular Chairman's Press Conference" at the Nomura Conference Plaza Nihonbashi (Chuo-ku, Tokyo). At the press conference, JPMA Chairman Yoshihiko Hatanaka spoke on "I. Creation and Evaluation of Drug Discovery Innovations. Creation and Evaluation of Drug Innovation," "II. Toward Reform of the NHI Drug Price System," and "III. The JPMA's basic stance and specific initiatives were explained. Seventy-two members of the press attended this press conference and engaged in a lively Q&A session.
Topics
- Lecture commemorating the completion of the new exhibition room "Drugs Room - Kusurium" at the Science Museum
- JPMA special program "Nuchigusui na Monogatari -Listen and Feel At Ease About Medicines-" broadcast by Okinawa Television Broadcasting Corporation was held
- Held the 22nd Environmental Safety Seminar
- U.S. Pharmaceutical Regulatory Affairs Seminar" - U.S. FDA's Proposed Revision of GLP to Strengthen the Quality System and Four Priority Review Programs for the Early Approval of Breakthrough New Drugs
- The 4th Taiwan-Japan Pharmaceutical Exchange Conference" was held.
- CMC Strategy Forum Japan 2016" was held.
Connecting with Citizens and Patients
Policy Research Institute
IoT (Internet of Things) in Medicine and Healthcare
From JPMA
Contributing to Society through the Creation of Innovative Medicines